NCT06950229

Brief Summary

Post-caesarean maternal infectious morbidity is still a big challenge despite prophylactic antibiotics and preoperative vaginal cleansing with povidone-iodine use in reduction of post-caesarean endometritis.Povidone iodine has been found to cause significant irritation to the vaginal mucosa especially in females with iodine hypersensitivity necessitating the study of efficacy of normal saline which has minimal side effects in the prevention of post caesarean complications

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
224

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 6, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 9, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 9, 2021

Completed
4.1 years until next milestone

First Submitted

Initial submission to the registry

April 22, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 30, 2025

Completed
Last Updated

May 2, 2025

Status Verified

April 1, 2025

Enrollment Period

5 months

First QC Date

April 22, 2025

Last Update Submit

April 29, 2025

Conditions

Keywords

Povidone IodineNormal SalineCaesarean sectionvaginal cleansing

Outcome Measures

Primary Outcomes (2)

  • Post caesarean endometritis.

    Patient that has at least two or more of the following signs and symptoms with no other recognized cause: fever greater than or equal to 380c, abdominal pain, uterine tenderness and purulent drainage from the uterus

    24 hours

  • Post operative vaginal irritation

    presence of symptoms like itching, burning, swelling and vaginal pain following the vaginal cleansing with either 5% povidone iodine or normal saline solution.

    24 hours

Study Arms (2)

Povidone group

ACTIVE COMPARATOR

Hundred (100) ml of 5% povidone iodine was poured into a sterilized bowl (galipot). Three pieces of gauze held with sponge holding forceps was dipped into the sterilized bowl containing 100mls of 5% povidone iodine and was allowed to be well soaked with 5% povidone iodine and thereafter used to swab the vulva in 360 degrees. one gram of ceftriaxone and 500mg of metronidazole was given prior to the procedure.

Drug: Povidone-Iodine

Normal Saline

EXPERIMENTAL

Hundred (100) ml of Normal saline was poured into a sterilized bowl (galipot). Three pieces of gauze held with sponge holding forceps was dipped into the sterilized bowl containing 100mls of Normal saline and was allowed to be well soaked with Normal saline and thereafter used to swab the vulva in 360 degrees. one gram of ceftriaxone and 500mg of metronidazole was given prior to the procedure.

Drug: Normal Saline

Interventions

Hundred (100) ml of 5% povidone iodine was poured into a sterilized bowl (galipot). Three pieces of gauze held with sponge holding forceps was dipped into the sterilized bowl containing 100mls of 5% povidone iodine and was allowed to be well soaked with 5% povidone iodine and thereafter used to swab the vulva in 360 degrees. one gram of ceftriaxone and 500mg of metronidazole was given prior to the procedure.

Povidone group

Hundred (100) ml of Normal saline was poured into a sterilized bowl (galipot). Three pieces of gauze held with sponge holding forceps was dipped into the sterilized bowl containing 100mls of Normal Saline and was allowed to be well soaked with Normal saline and thereafter used to swab the vulva in 360 degrees. one gram of ceftriaxone and 500 mg of metronidazole was given prior to the procedure.

Normal Saline

Eligibility Criteria

Age15 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • All consenting parturient for either elective or emergency caesarean section after the age of viability

You may not qualify if:

  • Women with known allergy to topical povidone-iodine.
  • Women with presence of pre-existing vaginal irritation symptoms as itching, burning, swelling and vaginal pain.
  • Antepartum haemorrhage (Placenta praevia).
  • Cord prolapse
  • Clinical evidence of Chorioamnionitis
  • Face presentation with ruptured membranes to avoid contact of fetal face with iodine.
  • Women with immunosupression due to HIV/AIDS, Diabetes Miletus or chronic use of steroids.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alex Ekwueme Federal University Teaching Hospital

Abakaliki, Ebonyi State, 480101, Nigeria

Location

MeSH Terms

Interventions

Povidone-IodineSaline Solution

Intervention Hierarchy (Ancestors)

IodophorsIodine CompoundsInorganic ChemicalsPolyvinylsVinyl CompoundsAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsPovidonePyrrolidinonesPyrrolidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPlasticsPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and AgricultureCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 22, 2025

First Posted

April 30, 2025

Study Start

October 6, 2020

Primary Completion

March 9, 2021

Study Completion

March 9, 2021

Last Updated

May 2, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations